Aptus Capital Advisors, LLC Bristol Myers Squibb CO Transaction History

Aptus Capital Advisors, LLC

$6.27 Billion
Q3 2024

A detailed history of Aptus Capital Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 21,738 shares of BMY stock, worth $1.26 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

21,738

Previous 17,317 25.53%

Holding current value

$1.26 Million

Previous $719,000 56.33%

% of portfolio

0.02%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$39.66 - $51.75 $175,336 - $228,786	4,421 Added 25.53%	21,738 $1.12 Million
Q2 2024 Jul 31, 2024	BUY	$40.25 - $52.99 $22,499 - $29,621	559 Added 3.34%	17,317 $719,000
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $110,593 - $125,392	2,305 Added 15.95%	16,758 $908,000
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $2.13 Million - $2.54 Million	-43,854 Reduced 75.21%	14,453 $741,000
Q3 2023 Nov 08, 2023	BUY	$57.89 - $64.73 $53,953 - $60,328	932 Added 1.62%	58,307 $3.38 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $208,586 - $231,602	-3,274 Reduced 5.4%	57,375 $3.67 Million
Q1 2023 May 09, 2023	BUY	$65.71 - $74.53 $1.11 Million - $1.26 Million	16,904 Added 38.64%	60,649 $4.2 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $220,642 - $261,271	3,222 Added 7.95%	43,745 $3.15 Million
Q3 2022 Nov 02, 2022	BUY	$0.13 - $76.84 $169 - $100,429	1,307 Added 3.33%	40,523 $2.88 Million
Q2 2022 Jul 29, 2022	BUY	$72.62 - $79.98 $2.25 Million - $2.48 Million	30,978 Added 376.04%	39,216 $3.03 Million
Q1 2022 May 04, 2022	BUY	$61.48 - $73.72 $506,472 - $607,305	8,238 New	8,238 $606,000
Q3 2020 Oct 19, 2020	SELL	$57.43 - $63.64 $2.74 Million - $3.04 Million	-47,750 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$54.82 - $64.09 $220,376 - $257,641	4,020 Added 9.19%	47,750 $2.81 Million
Q1 2020 May 07, 2020	BUY	$46.4 - $67.43 $243,600 - $354,007	5,250 Added 13.64%	43,730 $2.44 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $450,665 - $587,852	9,158 Added 31.23%	38,480 $2.45 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $1.25 Million - $1.49 Million	29,322 New	29,322 $1.49 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.

Account

Aptus Capital Advisors, LLC Bristol Myers Squibb CO Transaction History